跳到主要內容

Falberg Kathryn E 的 Form 4 申報

Nuvation Bio Inc.(NUVB),2022/12/5 申報

申報編號
0001209191-22-059756
申報時間
2022/12/5
交易日
2022/11/30-12/5
申報延遲
5 天遲報
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 4 筆非衍生性交易。公開市場買進合計 $48.3 萬。交易後 5 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Falberg Kathryn ECIK 0001206977董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/11/30Class A Common StockP買進取得+75,041$1.85F1+$138,825.8575,041間接
2022/12/1Class A Common StockP買進取得+84,959$1.97F3+$167,369.23160,000間接
2022/12/2Class A Common StockP買進取得+47,000$1.98F4+$93,060207,000間接
2022/12/5Class A Common StockP買進取得+43,000$1.95F4+$83,850250,000間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.805 to $1.90. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.92 to $1.99. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.925 to $2.00. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

表 I 有 2 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)